ARCG:LSE ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP

GBX 309.13 -2.78 ( -0.89%)
Icon

ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP (ARCG:LSE) Stock Analysis and Price Targets

ETF | Others | LSE

GBX 309.13

-2.78 (-0.89%)

GBX 8.76M

619.00

N/A

N/A

Icon

ARCG:LSE

ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP (GBX)
ETF | LSE
GBX 309.13
-2.78 ( -0.89%)
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 8.76M

N/A

GBX 309.13

ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP (ARCG:LSE) Stock Forecast

N/A

Stock Target Advisor’s own stock analysis of ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP is Very Bearish, which is based on 0 positive signals and 1 negative signals. At the last closing, ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP’s stock price was GBX 309.13. ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP’s stock price has changed by +7.61% over the past week, -10.87% over the past month and 0% over the last year.

No recent analyst target price found for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP
No recent average analyst rating found for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP

Company Overview ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP

http://www.ark-invest.com

N/A

N/A

N/A

GBX

UK

N/A

N/A

N/A

N/A

Adjusted Closing Price for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP (ARCG:LSE)

Loading...

Unadjusted Closing Price for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP (ARCG:LSE)

Loading...

Share Trading Volume for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP Shares

Loading...

Compare Performance of ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP Shares

ARCG:LSE VUKE:LSE
Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ARCG:LSE

Assets

N/A

Created with Highstock 5.0.6
Cash (0.00%)
NotClassified (0.00%)
Stock non-US (8.30%)
Other (0.00%)
Stock US (91.70%)
Bond (0.00%)

Top Sectors

N/A

Created with Highstock 5.0.6
Basic Materials (0.00%)
Consumer Cyclicals (0.00%)
Financial Services (0.00%)
Real Estate (0.00%)
Communication Services (0.00%)
Energy (0.00%)
Industrials (0.00%)
Technology (0.00%)
Consumer Defensive (0.00%)
Healthcare (100.00%)
Utilities (0.00%)

Top Regions

N/A

Created with Highstock 5.0.6
North America (91.79%)
United Kingdom (0.55%)
Europe Developed (7.65%)
Europe Emerging (0.00%)
Africa/Middle East (0.00%)
Japan (0.00%)
Australasia (0.00%)
Asia Developed (0.00%)
Asia Emerging (0.00%)
Latin America (0.00%)

Valuation Growth & Performance

  • N/A

  • Morningstar Gbl Health TME ...

  • N/A

  • 0.00

  • 0.00

  • 0.00

  • -20.61%

  • 0.00%

  • 0.00%

  • 0%

Stocks Similar To ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP (Sector: Others )

Frequently Asked Questions About ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP (ARCG:LSE) Stock

Stock Target Advisor's fundamental analysis for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP's stock is Very Bearish.

Unfortunately we do not have enough data on ARCG:LSE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on ARCG:LSE's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on ARCG:LSE's stock to indicate if its overvalued.

The last closing price of ARCG:LSE's stock was GBX 309.13.

The most recent market capitalization for ARCG:LSE is GBX 8.76M.

Unfortunately we do not have enough analyst data on ARCG:LSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP's stock.

Sorry, we do not have any data on the number of employees for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP.

Sorry we do not have any infomation available on ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP (ARCG:LSE) Stock

Stock Target Advisor's fundamental analysis for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP's stock is Very Bearish.

Unfortunately we do not have enough data on ARCG:LSE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on ARCG:LSE's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on ARCG:LSE's stock to indicate if its overvalued.

The last closing price of ARCG:LSE's stock was GBX 309.13.

The most recent market capitalization for ARCG:LSE is GBX 8.76M.

Unfortunately we do not have enough analyst data on ARCG:LSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP's stock.

Sorry, we do not have any data on the number of employees for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP.

Sorry we do not have any infomation available on ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP's address.
Loading...